NCT01786473View on ClinicalTrials.gov

Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism

PHASE3UnknownINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2014

Conditions
Hypogonadism
Interventions
DRUG

Testogel 1%

DRUG

Placebo

Trial Locations (1)

Unknown

RECRUITING

Peking University First Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Laboratoires Besins International

INDUSTRY

NCT01786473 - Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism | Biotech Hunter | Biotech Hunter